학술논문

Long-term safety of dupilumab in patients with moderate-to-severe asthma who completed the liberty asthma traverse continuation study
Document Type
Journal
Source
ALLERGY; DEC 2023, 78 p188-p189, 2p. Supplement: 112
Subject
Language
English
ISSN
13989995